About PulmoTech
PulmoTech is a Healthcare company based in Groningen (Netherlands) founded in 2018 by Rutger Flink, and was acquired by Sentec in April 2025. Smart devices for respiratory disease monitoring are developed by PulmoTech. Its chief executive, as recorded, is Rutger Flink. PulmoTech offers products and services including Intelligent Esophageal Pressure Catheter and Intelligent Esophageal Pressure System. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Monitoring Devices. Its legal entity is PulmoTech B.V.
Company details
PulmoTech was founded in 2018 in Groningen, Netherlands, and operates in the medical technology sector. Focus is placed on creating devices for respiratory monitoring, including an Esophageal Pressure Catheter equipped with feeding holes for enteral nutrition. Sensor technologies, such as spirometry integrated into ventilator systems, are utilized to measure lung pressure externally. Operations center on advancing non-invasive diagnostic tools for respiratory conditions.
- Headquarters Groningen, Netherlands
- Founders Rutger Flink
- Stage Acquired
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website pulmo-tech.com
- Social LinkedIn
- Acquired by Sentec (Apr 2025)
- Legal Name Pulmotech B.V.
Products & Services of PulmoTech
PulmoTech offers a comprehensive portfolio of products and services, including Intelligent Esophageal Pressure Catheter and Intelligent Esophageal Pressure System.
Catheter for measuring esophageal pressure and enteral feeding.
System combining pressure monitoring with feeding for patients.
Investors in PulmoTech
PulmoTech has secured backing from 1 investor. Prominent investors backing the company include SenTec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Develops innovative technologies for non-invasive patient monitoring solutions. | 1999 | sentec.com | Therwil, Switzerland |
Investor details for PulmoTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PulmoTech
1 people are tracked at PulmoTech (1 in leadership).
| Name | Role | Group |
|---|---|---|
Rutger Flink | Founder & CEO | Leadership |
Complete people profiles for PulmoTech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PulmoTech
2 dated milestones of PulmoTech across 7 years, from founding to its latest funding, stage changes and deals.
- Founded PulmoTech is founded.
- Exit Acquired by Sentec.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PulmoTech
PulmoTech was founded in 2018.
PulmoTech is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.
Rutger Flink is the CEO of PulmoTech, as recorded in our data. They have also founded this company.
PulmoTech was founded in 2018 in Groningen, Netherlands, and operates in the medical technology sector. Focus is placed on creating devices for respiratory monitoring, including an Esophageal Pressure Catheter equipped with feeding holes for enteral nutrition. Sensor technologies, such as spirometry integrated into ventilator systems, are utilized to measure lung pressure externally. Operations center on advancing non-invasive diagnostic tools for respiratory conditions.
PulmoTech offers Intelligent Esophageal Pressure Catheter and Intelligent Esophageal Pressure System.
PulmoTech has 1 investor. Key investors include SenTec.
PulmoTech operates through Pulmotech B.V..
Yes. PulmoTech was acquired by Sentec in April 2025.
